ALCAM and cancer: The heterogeneity of cancer cells in parental cells containing a mixture of CSC populations has shown a clear indication that the silencing of RARβ might have affected other CSCs populations, but not the CSC that shown positive for CD166+EpCAM+ and CD166-EpCAM-.